Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BOLD compared with PLRX: revenue, margins and what each company keeps, and the suppliers and customers both name
BOLD
Boundless Bio, Inc.
Change
Mkt cap
Revenue
Revenue
PLRX
Pliant Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BOLD
Boundless Bio, Inc.
vs
PLRX
Pliant Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BOLD
No earnings history for BOLD.
PLRX
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±55.4%
▲
+3.88%
×0.07
= implied
BOLD realized, solid
PLRX realized, hatched
One scale, both sides: full bar = 56%
× = |realized| ÷ implied
Source: market data
BOLD
Boundless Bio, Inc.
Change
2.38
▼
−1.24%
Mkt cap
$54.8M
Revenue
—
PLRX
Pliant Therapeutics, Inc.
Change
0.81
▼
−0.71%
Regular session
Nov 6 '26
Mkt cap
$52.7M
Revenue
$248,000
Q2 FY23
vs
Compare
Regular session
Nov 6 '26
BOLD
Boundless Bio, Inc.
vs
PLRX
Pliant Therapeutics, Inc.
2.38
▼
−1.24%
Price
0.81
▼
−0.71%
$54.8M
Mkt cap
$52.7M
—
Revenue
$248,000
Q2 FY23
Change
Change
BOLD
2.38
▼
−1.24%
vs
PLRX
0.81
▼
−0.71%
Regular session
Nov 6 '26